×

Use of equol for treating androgen mediated diseases

  • US 9,408,825 B2
  • Filed: 07/27/2015
  • Issued: 08/09/2016
  • Est. Priority Date: 10/29/2002
  • Status: Expired due to Term
First Claim
Patent Images

1. A method for treating or preventing a physiological or pathophysiological conditions of benign prostatic hyperplasia and prostate cancer and mediated by androgens in a mammal comprising:

  • administering to the mammal an effective amount of a composition consisting of;

    equol comprising a racemic mixture of R-equol and S-equol enantiomers; and

    at least one of a pharmaceutically, nutraceutically, or cosmetically acceptable carrier, adjuvant, or excipient,thereby treating or preventing the physiological and pathophysiological conditions of benign prostatic hyperplasia and prostate cancer.

View all claims
  • 2 Assignments
Timeline View
Assignment View
    ×
    ×